Lataa...
Subchronic oral toxicity studies of Se-methylselenocysteine, an organoselenium compound for breast cancer prevention
Se-methylselenocysteine (MSC) is an organoselenium compound being developed for breast cancer chemoprevention. To characterize MSC toxicity, CD rats received daily gavage doses of 0, 0.5, 1.0, or 2.0 mg/kg/day (0, 3, 6, or 12 mg/m(2)/day), and beagle dogs received daily gavage doses of 0, 0.15, 0.3,...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2007
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2279231/ https://ncbi.nlm.nih.gov/pubmed/18082924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.fct.2007.11.001 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|